- Home
- AUTL vs RGR Comparison
AUTL vs RGR Comparison
Compare AUTL & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- RGR
- Stock Information
- Founded
- AUTL 2014
- RGR 1949
- Country
- AUTL United Kingdom
- RGR United States
- Employees
- AUTL N/A
- RGR N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- RGR Ordnance And Accessories
- Sector
- AUTL Health Care
- RGR Industrials
- Exchange
- AUTL Nasdaq
- RGR Nasdaq
- Market Cap
- AUTL 590.8M
- RGR 627.3M
- IPO Year
- AUTL 2018
- RGR N/A
- Fundamental
- Price
- AUTL $1.95
- RGR $39.62
- Analyst Decision
- AUTL Strong Buy
- RGR
- Analyst Count
- AUTL 3
- RGR 0
- Target Price
- AUTL $10.20
- RGR N/A
- AVG Volume (30 Days)
- AUTL 1.2M
- RGR 151.8K
- Earning Date
- AUTL 03-13-2025
- RGR 02-19-2025
- Dividend Yield
- AUTL N/A
- RGR 1.77%
- EPS Growth
- AUTL N/A
- RGR N/A
- EPS
- AUTL N/A
- RGR 1.77
- Revenue
- AUTL $10,091,000.00
- RGR $535,643,000.00
- Revenue This Year
- AUTL $851.88
- RGR N/A
- Revenue Next Year
- AUTL $220.57
- RGR $4.81
- P/E Ratio
- AUTL N/A
- RGR $22.38
- Revenue Growth
- AUTL 82.71
- RGR N/A
- 52 Week Low
- AUTL $1.87
- RGR $34.11
- 52 Week High
- AUTL $6.63
- RGR $48.20
- Technical
- Relative Strength Index (RSI)
- AUTL 37.49
- RGR 73.01
- Support Level
- AUTL $1.92
- RGR $34.82
- Resistance Level
- AUTL $2.15
- RGR $40.83
- Average True Range (ATR)
- AUTL 0.12
- RGR 0.87
- MACD
- AUTL 0.01
- RGR 0.41
- Stochastic Oscillator
- AUTL 22.22
- RGR 79.87
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.